Frequent Mutation of rs13281615 and Its Association with PVT1 Expression and Cell Proliferation in Breast Cancer

Zhiqian Zhang; Zhengmao Zhu; Baotong Zhang; Weidong Li; Xin Li; Xiao Wu; Lijuan Wang; Liya Fu; Li Fu; Jin-Tang Dong

doi:10.1016/j.jgg.2014.03.006

Volume 41 Issue 4

Apr. 2014

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2014 > 41(4): 187-195

PDF( 1161 KB)

Frequent Mutation of rs13281615 and Its Association with PVT1 Expression and Cell Proliferation in Breast Cancer

doi: 10.1016/j.jgg.2014.03.006

a
Department of Genetics and Cell Biology, Nankai University College of Life Sciences, Tianjin 300071, China
b
Key Laboratory of Breast Cancer Research, Department of Breast Cancer Pathology and Research Laboratory, Cancer Hospital of Tianjin Medical University, Tianjin 300060, China
c
Department of Hematology and Medical Oncology, Emory University School of Medicine, Emory Winship Cancer Institute, Atlanta 30322, USA

More Information

Corresponding author: E-mail address: jtdongus@yahoo.com (Jin-Tang Dong)
Received Date: 2013-11-14
Accepted Date: 2014-03-27
Rev Recd Date: 2014-03-18

Available Online: 2014-04-05

Publish Date: 2014-04-20

Abstract

Abstract

The q24 band of chromosome 8 (8q24) is frequently amplified in human cancers including breast cancer, and several SNPs (single nucleotide polymorphisms) at 8q24, including rs13281615, have been identified for their association with cancer risks. These SNPs are in a “gene desert” region, and their functions in cancer development remain to be illustrated, although several of the SNPs appear to influence the genes in the “desert” in a long-range manner, including the v-myc avian myelocytomatosis viral oncogene homolog (MYC) and the non-protein coding plasmacytoma variant translocation 1 (PVT1), both of which have been implicated in human cancers. In the current study, we examined rs13281615 for its potential role in breast cancer using normal and cancer tissues from 121 Chinese women with breast cancer. In addition to confirming the association of the GG genotype of rs13281615 with breast cancer risk, we found that germline GG genotype was significantly associated with estrogen receptor (ER) positivity, higher tumor grade and higher proliferation index. We also found frequent somatic mutations (22/121 or 18.2%) of this SNP in breast cancer. Interestingly, the majority of the mutations (17/22 or 77%) involved a G→A change, resulting in a decrease in the number of cancers with the GG risk genotype and subsequent loss of GG association with higher tumor grade and proliferation index in cancers. Furthermore,PVT1 expression was increased in cancers, and the increase was associated with the GG genotype of rs13281615. These results suggest that the GG genotype of SNP rs13281615 plays a role in breast cancer likely by influencing PVT1 expression, and that during oncogenesis, “protective” mutations could occur.
- rs13281615,
- Mutation,
- Breast cancer

FullText(HTML)

References(39)

References

[1]	Ahmadiyeh, N., Pomerantz, M.M., Grisanzio, C. et al. Proc. Natl. Acad. Sci. USA, 107 (2010),pp. 9742-9746
[2]	Beck-Engeser, G.B., Lum, A.M., Huppi, K. et al. Retrovirology, 5 (2008),p. 4
[3]	Boehm, T., Rabbitts, T.H. The human T cell receptor genes are targets for chromosomal abnormalities in T cell tumors FASEB J., 3 (1989),pp. 2344-2359
[4]	Broeks, A., Schmidt, M.K., Sherman, M.E. et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium Hum. Mol. Genet., 20 (2011),pp. 3289-3303
[5]	Carramusa, L., Contino, F., Ferro, A. et al. J. Cell. Physiol., 213 (2007),pp. 511-518
[6]	Chan, M., Ji, S.M., Liaw, C.S. et al. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population Breast Cancer Res. Treat., 136 (2012),pp. 209-220
[7]	Dworkin, A.M., Ridd, K., Bautista, D. et al. Germline variation controls the architecture of somatic alterations in tumors PLoS Genet., 6 (2010),p. e1001136
[8]	Easton, D.F., Pooley, K.A., Dunning, A.M. et al. Genome-wide association study identifies novel breast cancer susceptibility loci Nature, 447 (2007),pp. 1087-1093
[9]	Feo, S., Di Liegro, C., Jones, T. et al. Oncogene, 9 (1994),pp. 955-961
[10]	Fletcher, O., Johnson, N., Gibson, L. et al. Association of genetic variants at 8q24 with breast cancer risk Cancer Epidemiol. Biomarkers Prev., 17 (2008),pp. 702-705
[11]	Futreal, P.A., Coin, L., Marshall, M. et al. A census of human cancer genes Nat. Rev. Cancer, 4 (2004),pp. 177-183
[12]	Garcia-Closas, M., Hall, P., Nevanlinna, H. et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics PLoS Genet., 4 (2008),p. e1000054
[13]	Ghoussaini, M., Song, H., Koessler, T. et al. Multiple loci with different cancer specificities within the 8q24 gene desert J. Natl. Cancer Inst., 100 (2008),pp. 962-966
[14]	Gold, B., Kirchhoff, T., Stefanov, S. et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33 Proc. Natl. Acad. Sci. USA, 105 (2008),pp. 4340-4345
[15]	Gong, W.F., Zhong, J.H., Xiang, B.D. et al. Single nucleotide polymorphism 8q24 rs13281615 and risk of breast cancer: meta-analysis of more than 100,000 cases PLoS ONE, 8 (2013),p. e60108
[16]	Guan, Y., Kuo, W.L., Stilwell, J.L. et al. Clin. Cancer Res., 13 (2007),pp. 5745-5755
[17]	Hanahan, D., Weinberg, R.A. The hallmarks of cancer Cell, 100 (2000),pp. 57-70
[18]	Jia, L., Landan, G., Pomerantz, M. et al. Functional enhancers at the gene-poor 8q24 cancer-linked locus PLoS Genet., 5 (2009),p. e1000597
[19]	Jiang, Y., Han, J., Liu, J. et al. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province Breast Cancer Res. Treat., 128 (2011),pp. 251-257
[20]	Knudson, A.G. Two genetic hits (more or less) to cancer Nat. Rev. Cancer, 1 (2001),pp. 157-162
[21]	Long, J., Shu, X.O., Cai, Q. et al. Evaluation of breast cancer susceptibility loci in Chinese women Cancer Epidemiol. Biomarkers Prev., 19 (2010),pp. 2357-2365
[22]	McInerney, N., Colleran, G., Rowan, A. et al. Low penetrance breast cancer predisposition SNPs are site specific Breast Cancer Res. Treat., 117 (2009),pp. 151-159
[23]	Meyer, K.B., Maia, A.T., O'Reilly, M. et al. PLoS Genet., 7 (2011),p. e1002165
[24]	Munger, K. Disruption of oncogene/tumor suppressor networks during human carcinogenesis Cancer Invest., 20 (2002),pp. 71-81
[25]	Nagoshi, H., Taki, T., Hanamura, I. et al. Cancer Res., 72 (2012),pp. 4954-4962
[26]	Odefrey, F., Stone, J., Gurrin, L.C. et al. Common genetic variants associated with breast cancer and mammographic density measures that predict disease Cancer Res., 70 (2010),pp. 1449-1458
[27]	Pathmanathan, N., Balleine, R.L. Ki67 and proliferation in breast cancer J. Clin. Pathol., 66 (2013),pp. 512-516
[28]	Pomerantz, M.M., Ahmadiyeh, N., Jia, L. et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer Nat. Genet., 41 (2009),pp. 882-884
[29]	Pomerantz, M.M., Beckwith, C.A., Regan, M.M. et al. Cancer Res., 69 (2009),pp. 5568-5574
[30]	Sotelo, J., Esposito, D., Duhagon, M.A. et al. Proc. Natl. Acad. Sci. USA, 107 (2010),pp. 3001-3005
[31]	Sur, I.K., Hallikas, O., Vaharautio, A. et al. Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors Science, 338 (2012),pp. 1360-1363
[32]	Takatsuno, Y., Mimori, K., Yamamoto, K. et al. Ann. Surg. Oncol., 20 (2013),pp. 1395-1402
[33]	Thomas, G., Jacobs, K.B., Kraft, P. et al. Nat. Genet., 41 (2009),pp. 579-584
[34]	Turnbull, C., Ahmed, S., Morrison, J. et al. Genome-wide association study identifies five new breast cancer susceptibility loci Nat. Genet., 42 (2010),pp. 504-507
[35]	Tuupanen, S., Turunen, M., Lehtonen, R. et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling Nat. Genet., 41 (2009),pp. 885-890
[36]	Wasserman, N.F., Aneas, I., Nobrega, M.A. Genome Res., 20 (2010),pp. 1191-1197
[37]	Wright, J.B., Brown, S.J., Cole, M.D. Mol. Cell. Biol., 30 (2010),pp. 1411-1420
[38]	You, L., Chang, D., Du, H.Z. et al. Biochem. Biophys. Res. Commun., 407 (2011),pp. 1-6
[39]	Zheng, W., Wen, W., Gao, Y.T. et al. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women J. Natl. Cancer Inst., 102 (2010),pp. 972-981